Verrica Pharmaceuticals Inc (VRCA)
8.78
+0.08
(+0.92%)
USD |
NASDAQ |
May 21, 13:54
Verrica Pharmaceuticals Revenue (Quarterly): 3.826M for March 31, 2024
Revenue (Quarterly) Chart
Historical Revenue (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | 3.826M |
December 31, 2023 | 1.988M |
September 30, 2023 | 2.917M |
June 30, 2023 | 0.182M |
March 31, 2023 | 0.037M |
December 31, 2022 | 0.068M |
September 30, 2022 | 8.319M |
Date | Value |
---|---|
June 30, 2022 | 0.214M |
March 31, 2022 | 0.431M |
December 31, 2021 | |
September 30, 2021 | |
June 30, 2021 | |
March 31, 2021 | 12.00M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (Quarterly) Range, Past 5 Years
0.037M
Minimum
Mar 2023
12.00M
Maximum
Mar 2021
2.998M
Average
1.210M
Median
Revenue (Quarterly) Benchmarks
Emergent BioSolutions Inc | 292.40M |
Macrogenics Inc | 9.104M |
Aquestive Therapeutics Inc | 12.05M |
Recursion Pharmaceuticals Inc | 13.49M |
Omega Therapeutics Inc | 2.36M |
Revenue (Quarterly) Related Metrics
Net Income (Quarterly) | -20.33M |
Total Expenses (Quarterly) | 22.42M |
EPS Diluted (Quarterly) | -0.44 |
Enterprise Value | 362.96M |
Gross Profit Margin (Quarterly) | 70.26% |
Profit Margin (Quarterly) | -531.4% |
Earnings Yield | -20.05% |
Normalized Earnings Yield | -19.42 |